NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)
Natpara Pivotal Study Published In The Lancet Diabetes & Endocrinology

Natpara Pivotal Study Published In The Lancet Diabetes & Endocrinology

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that its pivotal Phase 3 ...

NPS Pharmaceuticals Reports Gattex STEPS 2 Study To Be Presented At American College Of Gastroenterology Meeting

NPS Pharmaceuticals Reports Gattex STEPS 2 Study To Be Presented At American College Of Gastroenterology Meeting

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported that results from the ...

'Mad Money' Lightning Round: Buy, Buy, Buy Visa

'Mad Money' Lightning Round: Buy, Buy, Buy Visa

Cramer likes NPS Pharmaceuticals and Chenier Energy but 8x8 is too hot for him.

Jim Cramer's 'Mad Money' Recap: Upside and Downside Risks

Jim Cramer's 'Mad Money' Recap: Upside and Downside Risks

Cramer said it's clear by the lack of a major selloff that many investors hope for a last-minute secret deal from Congress to avoid the government shutdown.

Biotech Stock Mailbag: Celldex, Exelixis, Geron, NPS Pharma

Biotech Stock Mailbag: Celldex, Exelixis, Geron, NPS Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

NPS Pharmaceuticals To Present At Leerink Swann Rare Disease Roundtable

NPS Pharmaceuticals To Present At Leerink Swann Rare Disease Roundtable

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Leerink Swann Rare Disease Roundtable in New York on Wednesday, October 2, 2013 at 11:10 a.

Stocks Under $10 Weekly Summary

A new name joined the model portfolio this week and we used the market's volatility to trim one name and build up another.

NPS Pharmaceuticals To Present At NewsMakers In The Biotech Industry Conference

NPS Pharmaceuticals To Present At NewsMakers In The Biotech Industry Conference

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the BioCentury 20 th Annual NewsMakers in the Biotech Industry Conference in New York on Friday, September 27, 2013 at 8:30 a.

Stocks Under $10 Weekly Summary

We used the strength in the market this week to take some profits in one of our model portfolio positions.

Cramer's Top Stock Picks: AAPL CMG SBUX NPSP

Cramer's Top Stock Picks: AAPL CMG SBUX NPSP

Apple failed to over-deliver while Chipotle and Starbucks learned their lessons the hard way, Cramer said.

Cramer's 'Mad Money' Recap: Under-Promise and Over-Deliver

Cramer's 'Mad Money' Recap: Under-Promise and Over-Deliver

Never promise what can't be delivered because shareholders have the right not to be disappointed, Cramer said.

Ask SUT

This week, David Peltier answers questions from two subscribers about some specific model portfolio stocks.

Dr. Francois Nader, President And CEO Of NPS Pharmaceuticals, Appointed To Biotechnology Industry Organization’s Board Of Directors

Dr. Francois Nader, President And CEO Of NPS Pharmaceuticals, Appointed To Biotechnology Industry Organization’s Board Of Directors

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief ...

Stocks Under $10 Weekly Summary

The stock market started the month off with a bang this week and we used weakness in one model portfolio name to add to our position.

Stocks Under $10 Weekly Summary

We took advantage of the broad market weakness this week to add a new position to the model portfolio.

NPS Pharmaceuticals To Present At Morgan Stanley Global Healthcare Conference

NPS Pharmaceuticals To Present At Morgan Stanley Global Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Morgan Stanley 2013 Global Healthcare Conference in New York on Monday, September 9, 2013 at 11:45 a.

Stocks Under $10 Weekly Summary

As stocks rallied for the first time in three weeks, we used the upswing to add shares to one model portfolio name.

NPS Pharmaceuticals Inc (NPSP): Today's Featured Health Care Winner

NPS Pharmaceuticals Inc (NPSP): Today's Featured Health Care Winner

NPS Pharmaceuticals was a winner within the health care sector, rising $0.68 (3.0%) to $23.70 on average volume

Stocks Under $10 Weekly Summary

We put some cash to work in the model portfolio this week, using the weakness in the housing sector to add to two of our positions.

Stocks Under $10 Weekly Summary

We took advantage of this week's market pullback to add to a position and book gains in two others.

Cashing Out of a Pharma Holding

Better-than-expected results have prompted a nice additional pop in the stock, so we're selling our remaining shares.

NPS Pharmaceuticals Reports Second Quarter 2013 Financial Results And Provides Business Update

NPS Pharmaceuticals Reports Second Quarter 2013 Financial Results And Provides Business Update

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the second quarter...

Pharma Numbers Coming

We continue to believe this stock can trade up through $20,

Stocks Under $10 Weekly Summary

We used volatility in the market to make several trades for the model portfolio this week.

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Wedbush Securities Life Sciences Management Access Conference in New York on Tuesday, August 13, 2013 at 9:45 a.

Quick Take: Biotech's Next Big Thing Is Earnings

Quick Take: Biotech's Next Big Thing Is Earnings

It's time to review the mid-cap biotech stocks reporting second quarter results next week, says Adam Feuerstein, senior columnist at TheStreet.

Biotech's Next Big Thing: Earnings

Biotech's Next Big Thing: Earnings

It's time to review the mid-cap biotech stocks reporting second quarter results next week, says Adam Feuerstein, Sr. Columnist at TheStreet.

NPS Pharmaceuticals Enrolls First Patient In Global Registry Designed To Characterize The Natural History Of Hypoparathyroidism

NPS Pharmaceuticals Enrolls First Patient In Global Registry Designed To Characterize The Natural History Of Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced the company has initiated ...

Stocks Under $10 Weekly Summary

As earnings season pressed on this week, we booked some profits in one model portfolio name and built up our holding in another.

NPS Pharmaceuticals To Report Second Quarter 2013 Financial Results

NPS Pharmaceuticals To Report Second Quarter 2013 Financial Results

NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its second quarter 2013 financial results on Thursday, August 8, 2013 at approximately 4:30 p.